Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II pilot study of doxycycline + ursodeoxycholic acid in ATTR amyloidosis
2011-005236-25Phase 2Completed
- Sponsor
- Umeå University
- Start
- Nov 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ursodeoxycholic acid, doxycycline + ursodeoxycholic acid in transthyretin amyloidosis (ATTR), hereditary transthyretin amyloidosis (hATTR), amyloidotic transthyretin cardiomyopathy (ATTR-CM), sponsored by Umeå University. Started Nov 2011; status: completed.
02
Drugs
ursodeoxycholic aciddoxycycline + ursodeoxycholic acid
03
Conditions
transthyretin amyloidosis (ATTR)hereditary transthyretin amyloidosis (hATTR)amyloidotic transthyretin cardiomyopathy (ATTR-CM)
Beyond the preview
Go deeper on 2011-005236-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005236-25.